Global Neurologic Disorder Treatment Drug Market Growth (Status and Outlook) 2023-2028

Report ID: 1978612 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Neurologic Disorder Treatment Drug Market Size 2017-2028
        2.1.2 Neurologic Disorder Treatment Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Neurologic Disorder Treatment Drug Segment by Type
        2.2.1 Anticholinergic
        2.2.2 Antiepileptic
        2.2.3 Antipsychotic
        2.2.4 Hypnotic and Sedative
        2.2.5 Analgesics
        2.2.6 Antihypertensive
        2.2.7 Anticoagulants
        2.2.8 Others
    2.3 Neurologic Disorder Treatment Drug Market Size by Type
        2.3.1 Neurologic Disorder Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)
    2.4 Neurologic Disorder Treatment Drug Segment by Application
        2.4.1 Epilepsy
        2.4.2 Alzheimer’s Disease
        2.4.3 Parkinson's Disease
        2.4.4 Multiple Sclerosis
        2.4.5 Cerebrovascular Disease
        2.4.6 Others
    2.5 Neurologic Disorder Treatment Drug Market Size by Application
        2.5.1 Neurologic Disorder Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)
3 Neurologic Disorder Treatment Drug Market Size by Player
    3.1 Neurologic Disorder Treatment Drug Market Size Market Share by Players
        3.1.1 Global Neurologic Disorder Treatment Drug Revenue by Players (2020-2022)
        3.1.2 Global Neurologic Disorder Treatment Drug Revenue Market Share by Players (2020-2022)
    3.2 Global Neurologic Disorder Treatment Drug Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Neurologic Disorder Treatment Drug by Regions
    4.1 Neurologic Disorder Treatment Drug Market Size by Regions (2017-2022)
    4.2 Americas Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)
    4.3 APAC Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)
    4.4 Europe Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)
    4.5 Middle East & Africa Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Neurologic Disorder Treatment Drug Market Size by Country (2017-2022)
    5.2 Americas Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)
    5.3 Americas Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Neurologic Disorder Treatment Drug Market Size by Region (2017-2022)
    6.2 APAC Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)
    6.3 APAC Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Neurologic Disorder Treatment Drug by Country (2017-2022)
    7.2 Europe Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)
    7.3 Europe Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Neurologic Disorder Treatment Drug by Region (2017-2022)
    8.2 Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)
    8.3 Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Neurologic Disorder Treatment Drug Market Forecast
    10.1 Global Neurologic Disorder Treatment Drug Forecast by Regions (2023-2028)
        10.1.1 Global Neurologic Disorder Treatment Drug Forecast by Regions (2023-2028)
        10.1.2 Americas Neurologic Disorder Treatment Drug Forecast
        10.1.3 APAC Neurologic Disorder Treatment Drug Forecast
        10.1.4 Europe Neurologic Disorder Treatment Drug Forecast
        10.1.5 Middle East & Africa Neurologic Disorder Treatment Drug Forecast
    10.2 Americas Neurologic Disorder Treatment Drug Forecast by Country (2023-2028)
        10.2.1 United States Neurologic Disorder Treatment Drug Market Forecast
        10.2.2 Canada Neurologic Disorder Treatment Drug Market Forecast
        10.2.3 Mexico Neurologic Disorder Treatment Drug Market Forecast
        10.2.4 Brazil Neurologic Disorder Treatment Drug Market Forecast
    10.3 APAC Neurologic Disorder Treatment Drug Forecast by Region (2023-2028)
        10.3.1 China Neurologic Disorder Treatment Drug Market Forecast
        10.3.2 Japan Neurologic Disorder Treatment Drug Market Forecast
        10.3.3 Korea Neurologic Disorder Treatment Drug Market Forecast
        10.3.4 Southeast Asia Neurologic Disorder Treatment Drug Market Forecast
        10.3.5 India Neurologic Disorder Treatment Drug Market Forecast
        10.3.6 Australia Neurologic Disorder Treatment Drug Market Forecast
    10.4 Europe Neurologic Disorder Treatment Drug Forecast by Country (2023-2028)
        10.4.1 Germany Neurologic Disorder Treatment Drug Market Forecast
        10.4.2 France Neurologic Disorder Treatment Drug Market Forecast
        10.4.3 UK Neurologic Disorder Treatment Drug Market Forecast
        10.4.4 Italy Neurologic Disorder Treatment Drug Market Forecast
        10.4.5 Russia Neurologic Disorder Treatment Drug Market Forecast
    10.5 Middle East & Africa Neurologic Disorder Treatment Drug Forecast by Region (2023-2028)
        10.5.1 Egypt Neurologic Disorder Treatment Drug Market Forecast
        10.5.2 South Africa Neurologic Disorder Treatment Drug Market Forecast
        10.5.3 Israel Neurologic Disorder Treatment Drug Market Forecast
        10.5.4 Turkey Neurologic Disorder Treatment Drug Market Forecast
        10.5.5 GCC Countries Neurologic Disorder Treatment Drug Market Forecast
    10.6 Global Neurologic Disorder Treatment Drug Forecast by Type (2023-2028)
    10.7 Global Neurologic Disorder Treatment Drug Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 AbbVie
        11.1.1 AbbVie Company Information
        11.1.2 AbbVie Neurologic Disorder Treatment Drug Product Offered
        11.1.3 AbbVie Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 AbbVie Main Business Overview
        11.1.5 AbbVie Latest Developments
    11.2 Acadia Pharmaceuticals
        11.2.1 Acadia Pharmaceuticals Company Information
        11.2.2 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offered
        11.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Acadia Pharmaceuticals Main Business Overview
        11.2.5 Acadia Pharmaceuticals Latest Developments
    11.3 Acorda Therapeutics Biotechnology
        11.3.1 Acorda Therapeutics Biotechnology Company Information
        11.3.2 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offered
        11.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Acorda Therapeutics Biotechnology Main Business Overview
        11.3.5 Acorda Therapeutics Biotechnology Latest Developments
    11.4 Bayer
        11.4.1 Bayer Company Information
        11.4.2 Bayer Neurologic Disorder Treatment Drug Product Offered
        11.4.3 Bayer Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Bayer Main Business Overview
        11.4.5 Bayer Latest Developments
    11.5 Biogen
        11.5.1 Biogen Company Information
        11.5.2 Biogen Neurologic Disorder Treatment Drug Product Offered
        11.5.3 Biogen Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Biogen Main Business Overview
        11.5.5 Biogen Latest Developments
    11.6 CSK
        11.6.1 CSK Company Information
        11.6.2 CSK Neurologic Disorder Treatment Drug Product Offered
        11.6.3 CSK Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 CSK Main Business Overview
        11.6.5 CSK Latest Developments
    11.7 Eisai
        11.7.1 Eisai Company Information
        11.7.2 Eisai Neurologic Disorder Treatment Drug Product Offered
        11.7.3 Eisai Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Eisai Main Business Overview
        11.7.5 Eisai Latest Developments
    11.8 F. Hoffmann La Roche
        11.8.1 F. Hoffmann La Roche Company Information
        11.8.2 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offered
        11.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 F. Hoffmann La Roche Main Business Overview
        11.8.5 F. Hoffmann La Roche Latest Developments
    11.9 H Lundbeck
        11.9.1 H Lundbeck Company Information
        11.9.2 H Lundbeck Neurologic Disorder Treatment Drug Product Offered
        11.9.3 H Lundbeck Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 H Lundbeck Main Business Overview
        11.9.5 H Lundbeck Latest Developments
    11.10 Johnson and Johnson
        11.10.1 Johnson and Johnson Company Information
        11.10.2 Johnson and Johnson Neurologic Disorder Treatment Drug Product Offered
        11.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Johnson and Johnson Main Business Overview
        11.10.5 Johnson and Johnson Latest Developments
    11.11 Merck
        11.11.1 Merck Company Information
        11.11.2 Merck Neurologic Disorder Treatment Drug Product Offered
        11.11.3 Merck Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Merck Main Business Overview
        11.11.5 Merck Latest Developments
    11.12 Novartis
        11.12.1 Novartis Company Information
        11.12.2 Novartis Neurologic Disorder Treatment Drug Product Offered
        11.12.3 Novartis Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Novartis Main Business Overview
        11.12.5 Novartis Latest Developments
    11.13 Otsuka Pharmaceutical
        11.13.1 Otsuka Pharmaceutical Company Information
        11.13.2 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offered
        11.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Otsuka Pharmaceutical Main Business Overview
        11.13.5 Otsuka Pharmaceutical Latest Developments
    11.14 Pfizer
        11.14.1 Pfizer Company Information
        11.14.2 Pfizer Neurologic Disorder Treatment Drug Product Offered
        11.14.3 Pfizer Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Pfizer Main Business Overview
        11.14.5 Pfizer Latest Developments
    11.15 Sanofi
        11.15.1 Sanofi Company Information
        11.15.2 Sanofi Neurologic Disorder Treatment Drug Product Offered
        11.15.3 Sanofi Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Sanofi Main Business Overview
        11.15.5 Sanofi Latest Developments
    11.16 Takeda Pharmaceutical
        11.16.1 Takeda Pharmaceutical Company Information
        11.16.2 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offered
        11.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Takeda Pharmaceutical Main Business Overview
        11.16.5 Takeda Pharmaceutical Latest Developments
    11.17 Teva Pharmaceutical Industries
        11.17.1 Teva Pharmaceutical Industries Company Information
        11.17.2 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offered
        11.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Teva Pharmaceutical Industries Main Business Overview
        11.17.5 Teva Pharmaceutical Industries Latest Developments
    11.18 UCB
        11.18.1 UCB Company Information
        11.18.2 UCB Neurologic Disorder Treatment Drug Product Offered
        11.18.3 UCB Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 UCB Main Business Overview
        11.18.5 UCB Latest Developments
    11.19 USWM
        11.19.1 USWM Company Information
        11.19.2 USWM Neurologic Disorder Treatment Drug Product Offered
        11.19.3 USWM Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 USWM Main Business Overview
        11.19.5 USWM Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Neurologic Disorder Treatment Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Anticholinergic
    Table 3. Major Players of Antiepileptic
    Table 4. Major Players of Antipsychotic
    Table 5. Major Players of Hypnotic and Sedative
    Table 6. Major Players of Analgesics
    Table 7. Major Players of Antihypertensive
    Table 8. Major Players of Anticoagulants
    Table 9. Major Players of Others
    Table 10. Neurologic Disorder Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 12. Global Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)
    Table 13. Neurologic Disorder Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 14. Global Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 15. Global Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)
    Table 16. Global Neurologic Disorder Treatment Drug Revenue by Players (2020-2022) & ($ Millions)
    Table 17. Global Neurologic Disorder Treatment Drug Revenue Market Share by Player (2020-2022)
    Table 18. Neurologic Disorder Treatment Drug Key Players Head office and Products Offered
    Table 19. Neurologic Disorder Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 20. New Products and Potential Entrants
    Table 21. Mergers & Acquisitions, Expansion
    Table 22. Global Neurologic Disorder Treatment Drug Market Size by Regions 2017-2022 & ($ Millions)
    Table 23. Global Neurologic Disorder Treatment Drug Market Size Market Share by Regions (2017-2022)
    Table 24. Americas Neurologic Disorder Treatment Drug Market Size by Country (2017-2022) & ($ Millions)
    Table 25. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Country (2017-2022)
    Table 26. Americas Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 27. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)
    Table 28. Americas Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 29. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)
    Table 30. APAC Neurologic Disorder Treatment Drug Market Size by Region (2017-2022) & ($ Millions)
    Table 31. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Region (2017-2022)
    Table 32. APAC Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 33. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)
    Table 34. APAC Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 35. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)
    Table 36. Europe Neurologic Disorder Treatment Drug Market Size by Country (2017-2022) & ($ Millions)
    Table 37. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Country (2017-2022)
    Table 38. Europe Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)
    Table 40. Europe Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)
    Table 42. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Region (2017-2022) & ($ Millions)
    Table 43. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Region (2017-2022)
    Table 44. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 45. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)
    Table 46. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 47. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)
    Table 48. Key Market Drivers & Growth Opportunities of Neurologic Disorder Treatment Drug
    Table 49. Key Market Challenges & Risks of Neurologic Disorder Treatment Drug
    Table 50. Key Industry Trends of Neurologic Disorder Treatment Drug
    Table 51. Global Neurologic Disorder Treatment Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 52. Global Neurologic Disorder Treatment Drug Market Size Market Share Forecast by Regions (2023-2028)
    Table 53. Global Neurologic Disorder Treatment Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 54. Global Neurologic Disorder Treatment Drug Market Size Market Share Forecast by Type (2023-2028)
    Table 55. Global Neurologic Disorder Treatment Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 56. Global Neurologic Disorder Treatment Drug Market Size Market Share Forecast by Application (2023-2028)
    Table 57. AbbVie Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 58. AbbVie Neurologic Disorder Treatment Drug Product Offered
    Table 59. AbbVie Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. AbbVie Main Business
    Table 61. AbbVie Latest Developments
    Table 62. Acadia Pharmaceuticals Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 63. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offered
    Table 64. Acadia Pharmaceuticals Main Business
    Table 65. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 66. Acadia Pharmaceuticals Latest Developments
    Table 67. Acorda Therapeutics Biotechnology Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 68. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offered
    Table 69. Acorda Therapeutics Biotechnology Main Business
    Table 70. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 71. Acorda Therapeutics Biotechnology Latest Developments
    Table 72. Bayer Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 73. Bayer Neurologic Disorder Treatment Drug Product Offered
    Table 74. Bayer Main Business
    Table 75. Bayer Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 76. Bayer Latest Developments
    Table 77. Biogen Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 78. Biogen Neurologic Disorder Treatment Drug Product Offered
    Table 79. Biogen Main Business
    Table 80. Biogen Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 81. Biogen Latest Developments
    Table 82. CSK Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 83. CSK Neurologic Disorder Treatment Drug Product Offered
    Table 84. CSK Main Business
    Table 85. CSK Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 86. CSK Latest Developments
    Table 87. Eisai Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 88. Eisai Neurologic Disorder Treatment Drug Product Offered
    Table 89. Eisai Main Business
    Table 90. Eisai Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 91. Eisai Latest Developments
    Table 92. F. Hoffmann La Roche Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 93. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offered
    Table 94. F. Hoffmann La Roche Main Business
    Table 95. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 96. F. Hoffmann La Roche Latest Developments
    Table 97. H Lundbeck Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 98. H Lundbeck Neurologic Disorder Treatment Drug Product Offered
    Table 99. H Lundbeck Main Business
    Table 100. H Lundbeck Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 101. H Lundbeck Latest Developments
    Table 102. Johnson and Johnson Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 103. Johnson and Johnson Neurologic Disorder Treatment Drug Product Offered
    Table 104. Johnson and Johnson Main Business
    Table 105. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 106. Johnson and Johnson Latest Developments
    Table 107. Merck Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 108. Merck Neurologic Disorder Treatment Drug Product Offered
    Table 109. Merck Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Merck Main Business
    Table 111. Merck Latest Developments
    Table 112. Novartis Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 113. Novartis Neurologic Disorder Treatment Drug Product Offered
    Table 114. Novartis Main Business
    Table 115. Novartis Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 116. Novartis Latest Developments
    Table 117. Otsuka Pharmaceutical Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 118. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offered
    Table 119. Otsuka Pharmaceutical Main Business
    Table 120. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 121. Otsuka Pharmaceutical Latest Developments
    Table 122. Pfizer Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 123. Pfizer Neurologic Disorder Treatment Drug Product Offered
    Table 124. Pfizer Main Business
    Table 125. Pfizer Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 126. Pfizer Latest Developments
    Table 127. Sanofi Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 128. Sanofi Neurologic Disorder Treatment Drug Product Offered
    Table 129. Sanofi Main Business
    Table 130. Sanofi Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 131. Sanofi Latest Developments
    Table 132. Takeda Pharmaceutical Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 133. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offered
    Table 134. Takeda Pharmaceutical Main Business
    Table 135. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 136. Takeda Pharmaceutical Latest Developments
    Table 137. Teva Pharmaceutical Industries Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 138. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offered
    Table 139. Teva Pharmaceutical Industries Main Business
    Table 140. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 141. Teva Pharmaceutical Industries Latest Developments
    Table 142. UCB Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 143. UCB Neurologic Disorder Treatment Drug Product Offered
    Table 144. UCB Main Business
    Table 145. UCB Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 146. UCB Latest Developments
    Table 147. USWM Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors
    Table 148. USWM Neurologic Disorder Treatment Drug Product Offered
    Table 149. USWM Main Business
    Table 150. USWM Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 151. USWM Latest Developments
List of Figures
    Figure 1. Neurologic Disorder Treatment Drug Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Neurologic Disorder Treatment Drug Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Neurologic Disorder Treatment Drug Market Size Market Share by Type in 2021
    Figure 7. Neurologic Disorder Treatment Drug in Epilepsy
    Figure 8. Global Neurologic Disorder Treatment Drug Market: Epilepsy (2017-2022) & ($ Millions)
    Figure 9. Neurologic Disorder Treatment Drug in Alzheimer’s Disease
    Figure 10. Global Neurologic Disorder Treatment Drug Market: Alzheimer’s Disease (2017-2022) & ($ Millions)
    Figure 11. Neurologic Disorder Treatment Drug in Parkinson's Disease
    Figure 12. Global Neurologic Disorder Treatment Drug Market: Parkinson's Disease (2017-2022) & ($ Millions)
    Figure 13. Neurologic Disorder Treatment Drug in Multiple Sclerosis
    Figure 14. Global Neurologic Disorder Treatment Drug Market: Multiple Sclerosis (2017-2022) & ($ Millions)
    Figure 15. Neurologic Disorder Treatment Drug in Cerebrovascular Disease
    Figure 16. Global Neurologic Disorder Treatment Drug Market: Cerebrovascular Disease (2017-2022) & ($ Millions)
    Figure 17. Neurologic Disorder Treatment Drug in Others
    Figure 18. Global Neurologic Disorder Treatment Drug Market: Others (2017-2022) & ($ Millions)
    Figure 19. Global Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021
    Figure 20. Global Neurologic Disorder Treatment Drug Revenue Market Share by Player in 2021
    Figure 21. Global Neurologic Disorder Treatment Drug Market Size Market Share by Regions (2017-2022)
    Figure 22. Americas Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)
    Figure 23. APAC Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)
    Figure 24. Europe Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)
    Figure 25. Middle East & Africa Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)
    Figure 26. Americas Neurologic Disorder Treatment Drug Value Market Share by Country in 2021
    Figure 27. Americas Neurologic Disorder Treatment Drug Consumption Market Share by Type in 2021
    Figure 28. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021
    Figure 29. United States Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Canada Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Mexico Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Brazil Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 33. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Region in 2021
    Figure 34. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021
    Figure 35. China Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Japan Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Korea Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Southeast Asia Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 39. India Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Australia Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Country in 2021
    Figure 42. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Type in 2021
    Figure 43. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021
    Figure 44. Germany Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 45. France Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 46. UK Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Italy Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Russia Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Region in 2021
    Figure 50. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Type in 2021
    Figure 51. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021
    Figure 52. Egypt Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 53. South Africa Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 54. Israel Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 55. Turkey Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 56. GCC Country Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 57. Americas Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 58. APAC Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 59. Europe Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 60. Middle East & Africa Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 61. United States Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 62. Canada Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 63. Mexico Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 64. Brazil Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 65. China Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 66. Japan Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 67. Korea Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 68. Southeast Asia Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 69. India Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 70. Australia Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 71. Germany Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 72. France Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 73. UK Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 74. Italy Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 75. Russia Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 76. Spain Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 77. Egypt Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 78. South Africa Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 79. Israel Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 80. Turkey Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
    Figure 81. GCC Countries Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Neurologic Disorder Treatment Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Neurologic Disorder Treatment Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Neurologic Disorder Treatment Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports